UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The relevance of EMT in breast cancer metastasis: Correlation or causality?

FEBS letters, 2015-06, Vol.589 (14), p.1577-1587

2015

Volltextzugriff (PDF)

Tumor-infiltrating dendritic cell states are conserved across solid human cancers

The Journal of experimental medicine, 2021-01, Vol.218 (1)

2021

Volltextzugriff (PDF)

Distinct contributions of partial and full EMT to breast cancer malignancy

Developmental cell, 2021-12, Vol.56 (23), p.3203-3221.e11

2021

Volltextzugriff (PDF)

CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers

Science (American Association for the Advancement of Science), 2023-08, Vol.381 (6657), p.515-524

2023

Volltextzugriff (PDF)

Targeting Metabolic Symbiosis to Overcome Resistance to Anti-angiogenic Therapy

Cell reports (Cambridge), 2016-05, Vol.15 (6), p.1161-1174

2016

Volltextzugriff (PDF)

Autophagy Inhibition Improves Sunitinib Efficacy in Pancreatic Neuroendocrine Tumors via a Lysosome-dependent Mechanism

Molecular cancer therapeutics, 2017-11, Vol.16 (11), p.2502-2515

2017

Volltextzugriff (PDF)

Optimized antiangiogenic reprogramming of the tumor microenvironment potentiates CD40 immunotherapy

Proceedings of the National Academy of Sciences - PNAS, 2020-01, Vol.117 (1), p.541-551

2020

Volltextzugriff (PDF)

The FAK inhibitor BI 853520 exerts anti-tumor effects in breast cancer

Oncogenesis (New York, NY), 2018-09, Vol.7 (9), p.73-19, Article 73

2018

Volltextzugriff (PDF)

A Transgenic MMTV-Flippase Mouse Line for Molecular Engineering in Mammary Gland and Breast Cancer Mouse Models

Journal of mammary gland biology and neoplasia, 2019-03, Vol.24 (1), p.39-45

2019

Volltextzugriff (PDF)

Dual TLR9 and PD-L1 targeting unleashes dendritic cells to induce durable antitumor immunity

Journal for immunotherapy of cancer, 2023-05, Vol.11 (5), p.e006714

2023

Volltextzugriff (PDF)

Favorable response to mammalian target of rapamycin inhibition in a young patient with unresectable fibrolamellar carcinoma of the liver

Hepatology (Baltimore, Md.), 2018-07, Vol.68 (1), p.384-386

2018

Volltextzugriff (PDF)

Immuntherapie – Übersicht, Wirkmechanismen, Anwendung

Therapeutische Umschau, 2019-09, Vol.76 (4), p.187-194

2019

Volltextzugriff (PDF)

Diagnostic challenges and successful organ‐preserving therapy in a case of secretory carcinoma of minor salivary glands

Cancer reports, 2022-03, Vol.5 (3), p.e1491-n/a

2022

Volltextzugriff (PDF)

The Rip1Tag2 Transgenic Mouse Model

Methods in molecular biology (Clifton, N.J.), 2016-01, Vol.1464, p.151

2016

Volltextzugriff (PDF)

A neutrophil response linked to tumor control in immunotherapy

Cell, 2023-03, Vol.186 (7), p.1448-1464.e20

2023

Volltextzugriff (PDF)

Dendritic cells direct circadian anti-tumour immune responses

Nature (London), 2023-02, Vol.614 (7946), p.136-143

2023

Volltextzugriff (PDF)

Assessing PD-L1 Expression in Head and Neck Squamous Cell Carcinoma: Trials and Tribulations

Head & neck pathology (Totowa, N.J.), 2023-12, Vol.17 (4), p.969-975

2023

Volltextzugriff (PDF)

Circadian tumor infiltration and function of CD8+ T cells dictate immunotherapy efficacy

Cell, 2024-05, Vol.187 (11), p.2690-2702.e17

2024

Volltextzugriff (PDF)

Nintedanib Is a Highly Effective Therapeutic for Neuroendocrine Carcinoma of the Pancreas (PNET) in the Rip1Tag2 Transgenic Mouse Model

Clinical cancer research, 2015-11, Vol.21 (21), p.4856-4867

2015

Volltextzugriff (PDF)

VEGF receptor-2-specific signaling mediated by VEGF-E induces hemangioma-like lesions in normal and in malignant tissue

Angiogenesis (London), 2016-07, Vol.19 (3), p.339-358

2016

Volltextzugriff (PDF)

Macrophage-Targeted Therapy Unlocks Antitumoral Cross-talk between IFNγ-Secreting Lymphocytes and IL12-Producing Dendritic Cells

Cancer immunology research, 2022-01, Vol.10 (1), p.40-55

2022

Volltextzugriff (PDF)

An immature B cell population from peripheral blood serves as surrogate marker for monitoring tumor angiogenesis and anti-angiogenic therapy in mouse models

Angiogenesis (London), 2015-07, Vol.18 (3), p.327-345

2015

Volltextzugriff (PDF)

A high-content EMT screen identifies multiple receptor tyrosine kinase inhibitors with activity on TGFβ receptor

Oncotarget, 2016-05, Vol.7 (18), p.25983-26002

2016

Volltextzugriff (PDF)

PSGL-1 is dispensible for the development of active experimental autoimmune encephalomyelitis in SJL/J mice

Journal of neuroimmunology, 2011-03, Vol.232 (1), p.207-208

2011

Volltextzugriff (PDF)

1 – 25 von 59

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(47)

Publikationsform

Sprache

Englisch
(58)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(47)
Life Sciences & Biomedicine
(43)
Humans
(32)
Animals
(21)
Oncology
(19)
Mice
(18)
Female
(14)
Cancer
(12)
Cancer Research
(11)
Medicine
(11)
Medicine & Public Health
(11)
Cell Biology
(10)
Hematology
(9)
Immunology
(9)
Internal Medicine
(9)
Medicine/public Health
(9)
Biological And Medical Sciences
(8)
Critical Care Medicine
(8)
Hematologic And Hematopoietic Diseases
(8)
Immunodeficiencies. Immunoglobulinopathies
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The relevance of EMT in breast cancer metastasis: Correlation or causality?

Tumor-infiltrating dendritic cell states are conserved across solid human cancers

Distinct contributions of partial and full EMT to breast cancer malignancy

CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers

Targeting Metabolic Symbiosis to Overcome Resistance to Anti-angiogenic Therapy

Autophagy Inhibition Improves Sunitinib Efficacy in Pancreatic Neuroendocrine Tumors via a Lysosome-dependent Mechanism

Optimized antiangiogenic reprogramming of the tumor microenvironment potentiates CD40 immunotherapy

The FAK inhibitor BI 853520 exerts anti-tumor effects in breast cancer

A Transgenic MMTV-Flippase Mouse Line for Molecular Engineering in Mammary Gland and Breast Cancer Mouse Models

Dual TLR9 and PD-L1 targeting unleashes dendritic cells to induce durable antitumor immunity

Favorable response to mammalian target of rapamycin inhibition in a young patient with unresectable fibrolamellar carcinoma of the liver

Immuntherapie – Übersicht, Wirkmechanismen, Anwendung

Diagnostic challenges and successful organ‐preserving therapy in a case of secretory carcinoma of minor salivary glands

The Rip1Tag2 Transgenic Mouse Model

A neutrophil response linked to tumor control in immunotherapy

Dendritic cells direct circadian anti-tumour immune responses

Assessing PD-L1 Expression in Head and Neck Squamous Cell Carcinoma: Trials and Tribulations

Circadian tumor infiltration and function of CD8+ T cells dictate immunotherapy efficacy

Nintedanib Is a Highly Effective Therapeutic for Neuroendocrine Carcinoma of the Pancreas (PNET) in the Rip1Tag2 Transgenic Mouse Model

VEGF receptor-2-specific signaling mediated by VEGF-E induces hemangioma-like lesions in normal and in malignant tissue

Macrophage-Targeted Therapy Unlocks Antitumoral Cross-talk between IFNγ-Secreting Lymphocytes and IL12-Producing Dendritic Cells

Resident Kupffer cells and neutrophils drive liver toxicity in cancer immunotherapy

An immature B cell population from peripheral blood serves as surrogate marker for monitoring tumor angiogenesis and anti-angiogenic therapy in mouse models

A high-content EMT screen identifies multiple receptor tyrosine kinase inhibitors with activity on TGFβ receptor

PSGL-1 is dispensible for the development of active experimental autoimmune encephalomyelitis in SJL/J mice

Suchergebnisse filtern